Literature DB >> 12643461

Direct fibrin injection to promote new collateral growth in hind limb ischemia in a rabbit model.

Valeri S Chekanov1, Ramon Rayel, Victor Nikolaychik, Nicholas Kipshidze, Iskander Baibekov, Paul Karakozov, Tanvir Bajwa, Masood Akhtar.   

Abstract

UNLABELLED: Local stimulation of angiogenesis is a new approach for the treatment of critical limb ischemia. Our investigation tested intramuscular (i.m.) injection of a modified fibrin meshwork in a rabbit model.
METHODS: The left external iliac and femoral arteries were excised in 24 rabbits that were divided into four groups: control; i.m. saline injection; fibrin meshwork plus low dose (2.5 mg) fibrinogen i.m.; fibrin meshwork plus high-dose (5.0 mg) fibrinogen i.m. Angiography was performed before surgery, immediately after surgery, and one month postoperatively. Lower limb-calf blood pressure was measured immediately after surgery and at postoperative days 10, 20, and 30. On day 30, conventional indirect immunostaining was performed to determine the percentage of the area occupied by capillaries.
RESULTS: Immediately after surgery, in all four groups, the number of contract-opacified arteries (COA) crossing a specific segment of a grid decreased from 5.3 +/- 1.3 to 3.2 +/- 1.0 (p < 0.05); the number of grid intersections decreased from 30.2 +/- 6.5 to 19.3 +/- 4.8 (p < 0.05); and the total number of grids with COA decreased from 18.3 +/- 3.8 to 12.2 +/- 2.5 (p < 0.05). One month after surgery, in the control group, these parameters were 6.2 +/- 1.1, 33.2 +/- 5.7 and 20.3 +/- 1.5, respectively; in the saline-treated group, these parameters were 6.1 +/- 0.8, 28.3 +/- 6.9 and 19.8 +/- 1.1, respectively (p > 0.05 versus control and versus baseline data). When fibrin containing 5.0 mg fibrinogen was used, these parameters increased to 8.5 +/- 0.9, 48.3 +/- 5.1, and 27.1 +/- 0.9, respectively (p < 0.001 versus immediately after surgery and p < 0.05 versus control). In all four series, no Doppler flow signal was detected from the posterior tibial artery by day 10. By day 30, the lower limb-calf blood pressure ratio had improved in all four series, but was significantly improved in only the two groups treated with fibrin sealant (0.3 +/- 0.05 control; 0.3 +/- 0.08 saline; 0.6 +/- 0.06 fibrinogen 2.5; 0.7 +/- 0.05 fibrinogen 5.0).
CONCLUSION: Intramuscular injection of a fibrin meshwork considerably increased angiogenesis in the severely ischemic hind limb and may be strongly recommended for clinical use in patients with limb-threatening ischemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12643461     DOI: 10.1046/j.1540-8191.2002.01006.x

Source DB:  PubMed          Journal:  J Card Surg        ISSN: 0886-0440            Impact factor:   1.620


  5 in total

1.  Dose optimization of decellularized skeletal muscle extracellular matrix hydrogels for improving perfusion and subsequent validation in an aged hindlimb ischemia model.

Authors:  Melissa J Hernandez; Emma I Zelus; Martin T Spang; Rebecca L Braden; Karen L Christman
Journal:  Biomater Sci       Date:  2020-05-20       Impact factor: 6.843

2.  Improvement in angiogenesis and osteogenesis with modified cannulated screws combined with VEGF/PLGA/fibrin glue in femoral neck fractures.

Authors:  Licheng Zhang; Lihai Zhang; Xia Lan; Meng Xu; Zhi Mao; Houchen Lv; Qi Yao; Peifu Tang
Journal:  J Mater Sci Mater Med       Date:  2014-01-17       Impact factor: 3.896

3.  Hypoxic preconditioning-induced autophagy enhances survival of engrafted endothelial progenitor cells in ischaemic limb.

Authors:  Pei Zhou; Yu-Zhen Tan; Hai-Jie Wang; Guo-Dong Wang
Journal:  J Cell Mol Med       Date:  2017-04-04       Impact factor: 5.310

Review 4.  Therapeutic Biomaterial Approaches to Alleviate Chronic Limb Threatening Ischemia.

Authors:  Grazia Marsico; Sergio Martin-Saldaña; Abhay Pandit
Journal:  Adv Sci (Weinh)       Date:  2021-02-08       Impact factor: 16.806

5.  Designing Acellular Injectable Biomaterial Therapeutics for Treating Myocardial Infarction and Peripheral Artery Disease.

Authors:  Melissa J Hernandez; Karen L Christman
Journal:  JACC Basic Transl Sci       Date:  2017-04-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.